China Alzheimers disease Therapeutics Market: Segmented by Drug class (Cholinergic, Memantine, Combined drugs and others), Distribution channel (Hospital pharmacies, Retail Pharmacies and Online pharmacies) - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139820
- Pages: 200
-
Format:
Report Overview
The China Alzheimers disease therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD 2.206 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence and the targeted customers for the Alzheimers are the elderly population of any nation. The National Aged Population Office has published research in the Future Trends of Population Aging in China, which predicted that, by 2020, 248 million aged people, accounting for 17.17% of the whole population, will reside in China, and that aged 80 years or above will amount to 30.67 million, occupying a share of 12.37% of the total aged population.
Market Drivers
The increased prevalence of neurological disorder among the geriatric population is the major driving factor for the growth of Alzheimers drug market in china. Also, growing awareness as well as societal changes with respect to Alzheimers treatment and Knowledge about the innovative treatment is yet another factor promoting the growth of Alzheimers market in china. Advance R&D and technological advancements are promoting the growth of the therapeutics market in this segment.
1. China Alzheimers Disease Therapeutics Market Overview..........................
A. Market Size
2. Market Growth Drivers........................................................................................
A. Increasing prevalence of neurological disorders
B. Growing awareness and Societal changes
C. Advance R&D and technological advancements
3. Alzheimers disease stages...............................................................................
A. Stage 1
B. Stage 2
C. Stage 3
D. Stage 4
E. Stage 5
F. Stage 6
G. Stage 7
4. Alzheimers disease therapeutics Market Segmentation.............................
A. Drug type
I. Cholinergic
II. Memantine
III. Combined drugs
IV. Others
B. Distribution channels
I. Hospital pharmacies
II. Retail pharmacies
III. Online pharmacies
5. Alzheimers disease therapeutics Major Products Market Share...............
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape......................................................................................
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..........................................................................................
A. F. Hoffman La- Roche Company overview, Product & Services, Strategies & Financials
B Novartis A.G. Company overview, Product & Services, Strategies & Financials
C. Pfizer Inc Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape..............................................
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth..........................................................................
A. New Trends and Development of Alzheimers disease therapeutics market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
